The second largest acquisition Indian pharmaceutical industry, SunPharma’s $4 billion acquisition of Ranbaxy is making a lot of buzz in the world. What this acquisition is pointing towards? The size of the deal is greater than anyone’s imagination so there will be a great deal of hope invested by SunPharma founder Mr Dilip Sanghvi in this acquisition. Through this SunPharma has emerged as India’s most valuable company in the pharmaceutical segment. SunPharma was started 20 years back with a capital of 5 lakh made crores within a short time span. Not only that, SunPharma became the fifth largest pharmaceutical company in the world, through this deal, which specializes in speciality generic medicine. This is obviously a great victory for a company which started off with a single manufacturing unit in 1983, which grew so big that they started operating in 65 countries. With this move their revenue will be almost double to $4.3 million Lets think about the global impacts of this ac...
The global economy is grasping wide attention and this blog is an effort to provide an accurate information about those transitions,This blog is not complete without your valuable feedbacks. Feel free to comment